Formulation and optimization of electrospun nanofiber films for ultrafast delivery of domperidone: In vitro and in-vivo characterization

Abstract

Nanotechnology has significantly transformed drug delivery approaches by providing precise control of drug release kinetics and enhancing therapeutic effectiveness. Electrospun nanofiber films have unique features, including a significant surface-to-volume ratio and substantial porosity, resulting in enhanced patient adherence. The study was aimed at developing electrospun nanofiber films of domperidone for ultrafast release using polyvinyl alcohol (PVA). The nanofibers were prepared by electrospinning method and optimized using 32 factorial design. Electrospinning process parameters like feed rate, applied electric voltage, and tip-to-collector distance were optimized. The prepared nanofiber film was characterized using scanning electron microscopy, differential scanning calorimetry (DSC), Fourier transform infrared microscopy (FTIR), X ray diffraction (XRD), in-vitro diffusion, and permeation studies. The resultant domperidone-loaded nanofibers (diameters 280–565 nm) exhibited a uniform and highly porous structure. With an increase in applied voltage from 11 to 13 kV, entrapment efficiency increased, and fiber diameter decreased. DSC and XRD results confirmed the amorphous nature of the domperidone. The FTIR study confirmed the compatibility between domperidone and PVA. The wetting and disintegration times of nanofibers were 8 and 4 sec, respectively. Due to their nanosize, small particles with an increased surface area resulted in improved drug delivery through nanofibers (93.36% release within 10 min). The nanofiber film had a higher Cmax (398.8 ng/mL) and AUC (2078.593 ± 17.71 ng/mL.h) than the commercial tablet formulation (186.6 ng/mL and 1875.619 ± 10.38). Thus, domperidone nanofibers would be a promising approach for enhancing therapeutic and biopharmaceutical properties by providing ultra-fast delivery.